GSK raises $1.24 billion from latest Haleon stake sale By Reuters

[ad_1]


© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.

GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.

($1 = 0.7918 pounds)

[ad_2]

Source link


© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.

GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.

($1 = 0.7918 pounds)

Add a Comment

Your email address will not be published. Required fields are marked *